|
1
|
Sariego J: Breast cancer in the young
patient. Am Surg. 76:1397–1400. 2010.PubMed/NCBI
|
|
2
|
Boyle P and Levin B: World Health
Organization: World Cancer Report 2008. IARC Press; Lyon: pp.
42–43. 2008
|
|
3
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sant M, Allemani C, Capocaccia R,
Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P,
Martinez C, Bell J, et al: EUROCARE Working Group: Stage at
diagnosis is a key explanation of differences in breast cancer
survival across Europe. Int J Cancer. 106:416–422. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sotiriou C, Neo SY, McShane LM, Korn EL,
Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL and Liu ET: Breast
cancer classification and prognosis based on gene expression
profiles from a population-based study. Proc Natl Acad Sci USA.
100:10393–10398. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perou CM, Sørlie T, Eisen MB, et al:
Molecular portraits of human breast tumours. Nature. 406:747–752.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu Z, Fan C, Oh DS, Marron JS, He X,
Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, et al: The
molecular portraits of breast tumors are conserved across
microarray platforms. BMC Genomics. 7:962006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tripathi A, King C, de la Morenas A, Perry
VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M,
et al: Gene expression abnormalities in histologically normal
breast epithelium of breast cancer patients. Int J Cancer.
122:1557–1566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
R Development Core Team, . R: a language
and environment for statistical computing. http://www.R-project.orgThe R Foundation for
Statistical Computing; Vienna, Austria: 2013
|
|
10
|
Davis S and Meltzer PS: GEOquery: a bridge
between the Gene Expression Omnibus (GEO) and BioConductor.
Bioinformatics. 23:1846–1847. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:e32004.
|
|
13
|
Zheng Q and Wang XJ: GOEAST: a web-based
software toolkit for Gene Ontology enrichment analysis. Nucleic
Acids Res. 36:W358–W363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: The Gene Ontology Consortium: Gene ontology: Tool for the
unification of biology. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang B, Kirov S and Snoddy J: WebGestalt:
an integrated system for exploring gene sets in various biological
contexts. Nucleic Acids Res. 33:W741–W748. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duncan D, Prodduturi N and Zhang B:
WebGestalt2: an updated and expanded version of the Web-based Gene
Set Analysis Toolkit. BMC Bioinformatics. 11:102010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: a practical and powerful approach to
multiple testing. J R Statist Soc B. 57:289–300. 1995.
|
|
18
|
Tavassoli FA and Devilee P: World Health
Organization Classification of Tumours: Pathology and Genetics of
Tumours of the Breast and Female Genital Organs. IARC Press; Lyon,
France: pp. 116–119. 2003
|
|
19
|
Thomas EA, Coppola G, Desplats PA, et al:
The HDAC inhibitor 4b ameliorates the disease phenotype and
transcriptional abnormalities in Huntington's disease transgenic
mice. Proc Natl Acad Sci USA. 105:15564–15569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greenbaum D, Colangelo C, Williams K and
Gerstein M: Comparing protein abundance and mRNA expression levels
on a genomic scale. Genome Biol. 4:1172003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Menendez JA, Vellon L, Mehmi I, Teng PK,
Griggs DW and Lupu R: A novel CYR61-triggered ‘CYR61-alphavbeta3
integrin loop’ regulates breast cancer cell survival and
chemosensitivity through activation of ERK1/ERK2 MAPK signaling
pathway. Oncogene. 24:761–779. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gilchrist M, Thorsson V, Li B, Rust AG,
Korb M, Roach JC, Kennedy K, Hai T, Bolouri H and Aderem A: Systems
biology approaches identify ATF3 as a negative regulator of
Toll-like receptor 4. Nature. 441:173–178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malkin D, Li FP, Strong LC, Fraumeni JF
Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA,
et al: Germ line p53 mutations in a familial syndrome of breast
cancer, sarcomas, and other neoplasms. Science. 250:1233–1238.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharma SC and Richards JS: Regulation of
AP1 (Jun/Fos) factor expression and activation in ovarian granulosa
cells. Relation of JunD and Fra2 to terminal differentiation. J
Biol Chem. 275:33718–33728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McClung CA and Nestler EJ: Regulation of
gene expression and cocaine reward by CREB and DeltaFosB. Nat
Neurosci. 6:1208–1215. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yeung ML, Yasunaga J, Bennasser Y, Dusetti
N, Harris D, Ahmad N, Matsuoka M and Jeang KT: Roles for microRNAs,
miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1
tumor suppressor in cell growth dysregulation by human T-cell
lymphotrophic virus 1. Cancer Res. 68:8976–8985. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Card DAG, Hebbar PB, Li L, Trotter KW,
Komatsu Y, Mishina Y and Archer TK: Oct4/Sox2-regulated miR-302
targets cyclin D1 in human embryonic stem cells. Mol Cell Biol.
28:6426–6438. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suh M-R, Lee Y, Kim JY, Kim SK, Moon SH,
Lee JY, Cha KY, Chung HM, Yoon HS, Moon SY, et al: Human embryonic
stem cells express a unique set of microRNAs. Dev Biol.
270:488–498. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Greco SJ and Rameshwar P: MicroRNAs
regulate synthesis of the neurotransmitter substance P in human
mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci
USA. 104:15484–15489. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang Q, Gumireddy K, Schrier M, le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Keklikoglou I, Koerner C, Schmidt C, Zhang
JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T,
Schneeweiss A, et al: MicroRNA-520/373 family functions as a tumor
suppressor in estrogen receptor negative breast cancer by targeting
NF-κB and TGF-β signaling pathways. Oncogene. 31:4150–4163. 2012.
View Article : Google Scholar : PubMed/NCBI
|
